It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The Mulibrey (Muscle–liver–brain–eye) nanism caused by loss-of-function variants in TRIM37 gene is an autosomal recessive disorder characterized by severe growth failure and constrictive pericarditis. These patients also suffer from severe respiratory infections, co-incident with an increased mortality rate. Here, we revealed that TRIM37 variants were associated with recurrent infection. Trim37 FINmajor (a representative variant of Mulibrey nanism patients) and Trim37 knockout mice were susceptible to influenza virus infection. These mice showed defects in follicular helper T (TFH) cell development and antibody production. The effects of Trim37 on TFH cell differentiation relied on its E3 ligase activity catalyzing the K27/29-linked polyubiquitination of Bcl6 and its MATH domain-mediated interactions with Bcl6, thereby protecting Bcl6 from proteasome-mediated degradation. Collectively, these findings highlight the importance of the Trim37-Bcl6 axis in controlling the development of TFH cells and the production of high-affinity antibodies, and further unveil the immunologic mechanism underlying recurrent respiratory infection in Mulibrey nanism.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000000121679639); Chinese Academy of Sciences, University of Chinese Academy of Sciences, State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419)
2 Chinese Academy of Sciences, University of Chinese Academy of Sciences, State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Shanghai, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419)
3 Institute of Pasteur of Shanghai, Shanghai, China (GRID:grid.429007.8) (ISNI:0000 0004 0627 2381); Shanghai Tech University, School of Life Science and Technology, Shanghai, China (GRID:grid.440637.2) (ISNI:0000 0004 4657 8879)
4 Children’s Hospital of Fudan University, National Children’s Medical Center, Center for Molecular Medicine, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968)
5 Children’s Hospital of Fudan University, National Children’s Medical Center, Department of Allergy and Clinical Immunology, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968)
6 Institute of Pasteur of Shanghai, Shanghai, China (GRID:grid.429007.8) (ISNI:0000 0004 0627 2381)
7 Eye and ENT Hospital of Fudan University, Department of Ophthalmology, Shanghai, China (GRID:grid.411079.a) (ISNI:0000 0004 1757 8722)
8 University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000000121679639)
9 Children’s Hospital of Fudan University, National Children’s Medical Center, Center for Molecular Medicine, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968); Children’s Hospital of Fudan University, National Children’s Medical Center, Department of Neonatology, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968)
10 Third Military Medical University, Institute of Immunology, Chongqing, China (GRID:grid.410570.7) (ISNI:0000 0004 1760 6682); Beijing Changping Laboratory, Beijing, China (GRID:grid.410570.7)